CrossRef Text and Data Mining
Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.
Open-label, Randomized Comparison of the Efficacy of Intravenous Dolasetron Mesylate and Ondansetron in the Prevention of Acute and Delayed Cisplatin-induced Emesis in Cancer Patients
Jin-Soo Kim, Ji Yeon Baek, Sook Ryun Park, In Sil Choi, Sang-Il Kim, Dong-Wan Kim, Seock-Ah Im, Tae-You Kim, Dae Seog Heo, Yung-Jue Bang, Noe Kyeong Kim
Cancer Research and Treatment. 2004;36(6):372-376.   Published online 2004 December 31    DOI: https://doi.org/10.4143/crt.2004.36.6.372

Excel Download

Open-label, Randomized Comparison of the Efficacy of Intravenous Dolasetron Mesylate and Ondansetron in the Prevention of Acute and Delayed Cisplatin-induced Emesis in Cancer Patients
Cancer Research and Treatment. 2004;36(6):372   Crossref logo
Link1 Link2

1224 An open label study of tropisetron for acute and delayed cisplatin-induced emesis
European Journal of Cancer. 1995;31:S256   Crossref logo
Link1 Link2

Efficacy of granisetron for the prevention of cisplatin-induced emesis in lung cancer patients
Lung Cancer. 1994;11:88   Crossref logo
Link1 Link2

A Randomized, Multicenter, Open-Label Comparison of the Antiemetic Efficacy of Dolasetron Versus Ondansetron for the Prevention of Nausea and Vomiting During High-Dose Myeloablative Chemotherapy
Supportive Cancer Therapy. 2005;2(2):114-121   Crossref logo
Link1 Link2

Randomized double-blind comparison of three dose levels of intravenous ondansetron in the prevention of cisplatin-induced emesis
Cancer Chemotherapy and Pharmacology. 1993;32(4):268-272   Crossref logo
Link1 Link2 Link3

Methylprednisolone enhances the efficacy of ondansetron in acute and delayed cisplatin-induced emesis over at least three cycles
British Journal of Cancer. 1994;70(6):1171-1175   Crossref logo
Link1 Link2 Link3

A Double-Blind, Crossover, Randomized Comparison of Granisetron and Ramosetron for the Prevention of Acute and Delayed Cisplatin-Induced Emesis in Patients with Gastrointestinal Cancer: Is Patient Preference a Better Primary Endpoint?
Chemotherapy. 2003;49(6):316-323   Crossref logo
Link1 Link2

Adding ondansetron to dexamethasone does not reduce delayed cisplatin-induced emesis
Evidence-based Oncology. 2002;3(2):69-70   Crossref logo
Link1 Link2

Comparison of the anti-emetic efficacy of different doses of ondansetron, given as either a continuous infusion or a single intravenous dose, in acute cisplatin-induced emesis. A multicentre, double-blind, randomised, parallel group study
British Journal of Cancer. 1992;66(1):192-197   Crossref logo
Link1 Link2 Link3

An interaction of ondansetron and dexamethasone antagonizing cisplatin-induced acute and delayed emesis in the ferret
British Journal of Pharmacology. 1996;118(2):209-214   Crossref logo
Link1

This metadata service is kindly provided by CrossRef from May 29, 2014. Cancer Res Treat has participated in CrossRef Text and Data Mining service since October 29, 2014.